These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11468859)

  • 21. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The appropriateness of colorectal cancer screening by fecal occult blood tests.
    Lippi G; Brocco G; Guidi GC
    Am J Gastroenterol; 2008 Mar; 103(3):800-1. PubMed ID: 18341499
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
    Sung J
    Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 30. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
    [No Abstract]   [Full Text] [Related]  

  • 31. Is population screening for colorectal cancer cost-effective?
    Pignone M
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):288-9. PubMed ID: 16265263
    [No Abstract]   [Full Text] [Related]  

  • 32. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of fecal occult-blood testing.
    Bond JH; Mandel JS; Church TR
    N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
    [No Abstract]   [Full Text] [Related]  

  • 35. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Fletcher RH; Ransohoff DF; Imperiale TF
    Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
    [No Abstract]   [Full Text] [Related]  

  • 38. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

  • 40. [Health economics analysis of colorectal screening].
    Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
    Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.